TP53 and cancer: Interestingly, evidence of whole-genome doubling (WGD)—the duplication of at least 50% of the current set of chromosomes—is seen in 30–40% of all cancers, and it is correlated with prior loss of p53 function in more than half of the cases (Gerstung et al. 2020; Bielski et al. 2018).